Your browser doesn't support javascript.
loading
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia.
Fournier, Elise; Duployez, Nicolas; Ducourneau, Benoît; Raffoux, Emmanuel; Turlure, Pascal; Caillot, Denis; Thomas, Xavier; Marceau-Renaut, Alice; Chantepie, Sylvain; Malfuson, Jean-Valère; Lemasle, Emilie; Cheok, Meyling; Celli-Lebras, Karine; Guerin, Estelle; Terré, Christine; Lambert, Juliette; Pautas, Cécile; Dombret, Hervé; Castaigne, Sylvie; Preudhomme, Claude; Boissel, Nicolas.
Affiliation
  • Fournier E; Laboratory of Hematology, Centre Hospitalo-Universitaire de Lille, INSERM Unité Mixte de Recherche en Santé (UMR-S) 1172, Lille University, Lille, France.
  • Duployez N; Laboratory of Hematology, Centre Hospitalier de Dunkerque, Dunkerque, France.
  • Ducourneau B; Laboratory of Hematology, Centre Hospitalo-Universitaire de Lille, INSERM Unité Mixte de Recherche en Santé (UMR-S) 1172, Lille University, Lille, France.
  • Raffoux E; Laboratory of Hematology, Centre Hospitalo-Universitaire de Lille, INSERM Unité Mixte de Recherche en Santé (UMR-S) 1172, Lille University, Lille, France.
  • Turlure P; Laboratory of Hematology, Centre Hospitalier de Valenciennes, Valenciennes, France.
  • Caillot D; Department of Hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Thomas X; Department of Hematology, Centre Hospitalo-Universitaire de Limoges, Limoges University, Limoges, France.
  • Marceau-Renaut A; Department of Hematology, Centre Hospitalo-Universitaire de Dijon, Dijon, France.
  • Chantepie S; Department of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
  • Malfuson JV; Laboratory of Hematology, Centre Hospitalo-Universitaire de Lille, INSERM Unité Mixte de Recherche en Santé (UMR-S) 1172, Lille University, Lille, France.
  • Lemasle E; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France.
  • Cheok M; Department of Hematology, Hôpital d'Instruction des Armées Percy, Clamart, France.
  • Celli-Lebras K; Henri-Becquerel Cancer Center, Rouen, France.
  • Guerin E; Laboratory of Hematology, Centre Hospitalo-Universitaire de Lille, INSERM Unité Mixte de Recherche en Santé (UMR-S) 1172, Lille University, Lille, France.
  • Terré C; Department of Hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Lambert J; Laboratory of Hematology, Centre Hospitalo-Universitaire de Limoges, INSERM UMR-S 7276, Limoges University, Limoges, France.
  • Pautas C; Department of Medical Genetics, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Dombret H; Department of Hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Castaigne S; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France; and.
  • Preudhomme C; Department of Hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Boissel N; Department of Hematology, Centre Hospitalier de Versailles, Le Chesnay, France.
Blood ; 135(8): 542-546, 2020 02 20.
Article in En | MEDLINE | ID: mdl-31880804

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents, Immunological / Gemtuzumab / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans / Middle aged Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents, Immunological / Gemtuzumab / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans / Middle aged Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: France